TAYLOR JACOBY: Open Payments
NPI 1184099327 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 44 payments from 9 companies in 2025. Trend: 2023 $188 · 2024 $370 · 2025 $901
Food & beverage: $817Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $449 |
| Janssen Biotech, Inc. | 7 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| GENZYME CORPORATION | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Celltrion USA Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: RINVOQ, TREMFYA, SKYRIZI, ENTYVIO, DUPIXENT, ZENPEP, XIFAXAN, OMVOH.
Industry payments across IN — which companies pay providers there.
